REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 70 filers reported holding REGULUS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 3.91 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $0 | – | 300,000 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 300,000 | 0.0% | 0.00% | – |
| Q1 2016 | $1,000 | -95.2% | 300,000 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $21,000 | +320.0% | 300,000 | 0.0% | 0.00% | – |
| Q3 2015 | $5,000 | -97.0% | 300,000 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $164,000 | -87.9% | 300,000 | -7.8% | 0.01% | -89.1% |
| Q1 2015 | $1,354,000 | -1.4% | 325,532 | -5.1% | 0.09% | +80.4% |
| Q4 2014 | $1,373,000 | – | 343,055 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
| Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
| ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
| Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
| Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
| Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
| DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
| ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |